Delivery Order SPE2DB22D3501-SPE2DB24FVE91

Award Date 4/8/24
Potential Completion Date 4/9/24
Potential Value $34K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ONDANSETRON ODT 8 MG TABLET 30S. The delivery order has a potential value of $2,532.07 and a period of performance through March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which does not include any set-aside designation. This delivery order is issued under an indefinite delivery...
The U.S. Defense Logistics Agency (DLA) awarded a $5,001.12 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563774508 - ONDANSETRON ODT 4 MG TABLET 30S. This award has a completion date of February 27, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $4,390.37, is for the delivery of 4,563,925,340 units of ONDANSETRON ODT 8 MG TABLET 30S, a pharmaceutical product, to DLA Troop Support Medical facilities in support of military treatment programs and facilities. This delivery...
The Defense Logistics Agency (DLA) awarded a $3,888.14 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563488221 ONDANSETRON ODT 4 MG TABLET 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for...
This $47,700.78 delivery order contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4565733769 ONDANSETRON ODT 4 MG TABLET 30S. The contract has a firm fixed price and an ultimate completion date of September 10, 2024. Amerisourcebergen holds a broader indefinite delivery contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a range of medical...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $25,596.81 firm-fixed-price delivery order by the Defense Logistics Agency (DLA) to provide ONDANSETRON ODT 4 MG TABLET 30S, a pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of Ondansetron ODT 4 mg tablets. The order, valued at $3,672.70, has a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $44,840.82 contract is for the delivery of ONDANSETRON ODT 4 MG TABLET UD 30S to support military treatment programs and facilities. AmerisourceBergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to the Department of Defense. This delivery...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide ONDANSETRON ODT 4 MG TABLET 30S. The award, valued at $35,944.76, has a completion date of February 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and there were no set-aside designations for this contract. This delivery order is part of Amerisourcebergen Drug Corp's broader indefinite delivery contract (IDC) with...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order worth $2,195.36 by the Defense Logistics Agency (DLA) to provide 4563849936 ONDANSETRON ODT 4 MG TABLET 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 with a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FVE91
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564206369 ONDANSETRON ODT 4 MG TABLET 30S. The contract has a ceiling value of $34,214.41 and a period of performance through April 9, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp to supply a comprehensive range of pharmaceutical products and medical supplies to military treatment programs and facilities worldwide. The contract does not have any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on this award, and its parent company is Cencora, Inc., which does business as Amerisourcebergen.

Generated 7/8/24, 9:30 AM